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Abstract 
Background: Iodine deficiency is a major public health problem in many developing countries including Nepal. The 
present study was designed to investigate the urinary iodine excretion (UIE), thyroid function status and household 
salt iodine content (SIC) in school-aged children (SAC) and to establish the relationships between these factors.
Methods: A community-based cross sectional study was conducted in selected schools of two districts, Tehrathum 
and Morang, lying in the hill and plain region of eastern Nepal respectively. A total of 640 SAC, (Tehrathum n = 274 
and Morang n = 366) aged 6–11 years, were assessed for UIE and household SIC. Among the 640 children, 155 
consented to blood samples (Tehrathum n = 78 and Morang n = 77) to test for serum thyroglobulin (Tg), thyroid 
stimulating hormone (TSH), free triiodothyronine (fT3) and free thyroxine (fT4). UIE was measured by ammonium per-
sulfate digestion method. SIC was measured by iodometric titration method and Tg, TSH, fT4 and fT3 were measured 
by immunoassay based kit method.
Results: In Tehrathum and Morang, 9.5 and 7.7 % of SAC had UIE values of UIE <100 µg/L while 59.5 and 41 % had 
iodine nutrition values of >299 µg/L, with median UIE of 345.65 and 270.36 µg/L respectively. The overall medians 
were as follows, Tg 14.29 µg/L, fT3 3.94 pmol/L, fT4 16.25 pmol/L and TSH 3.61 mIU/L. There was a negative correlation 
between UIE and Tg (r = −0.236, p = 0.003) and a positive correlation between UIE and SIC (r = 0.349, p < 0.0001). We 
found 19.5 %, n = 15 and 16.7 %, n = 13 subclinical hypothyroid cases in Morang and Tehrathum respectively. Iodo-
metric titration showed only 6.4% (n = 41) of the samples had household SIC <15 ppm. Multivariate analysis revealed 
that use of packaged salt by SAC of Tehrathum district correlated with higher UIE values.
Conclusions: Our focused data suggests that collaborative universal salt iodization (USI) programs are improving the 
health of children in the Tehrathum and Morang districts of Nepal. We also found that excessive iodine in a large por-
tion of the study groups is a substantial concern and iodine intervention programs need to deal with both deficient 
and excessive iodine scenarios that can both be present simultaneously in study populations.
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Background
Iodine deficiency (ID) is a major public health problem 
globally, including Nepal [1]. It affects the population of 
all age groups but neonates, infants, pregnant women 
and school children constitute the most vulnerable 
groups [2]. Although remarkable progress has been made 
in the control of iodine deficiency disorders (IDD), they 
still remain a significant global public health problem 
particularly in developing countries [3]. The most severe 
outcomes of ID are increased perinatal mortality and 
mental retardation. ID is considered as the most com-
mon cause of brain damage in childhood which can be 
prevented, if appropriate measures are taken sufficiently 
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early [4, 5]. Thyroid hormone plays a critical role during 
brain development [6]. The most common thyroid dis-
orders in areas of excess iodine intake are autoimmune 
thyroid diseases, nodular goiter and iodine-induced 
hyperthyroidism [7, 8].
The World Health Organization (WHO) estimated the 
worldwide prevalence of ID using urinary iodine excre-
tion (UIE) data sampling 92 % of the world’s population 
from 1993 to 2003 [4]. Nearly two billion individuals have 
inadequate iodine status (UIE <100 µg/L). Occurrence of 
ID was observed in 36.4 % of school-aged children (SAC). 
Various indicators are used to investigate the iodine sta-
tus of a population: thyroid size, urinary iodine content, 
blood levels of thyroid stimulating hormone (TSH), and 
serum thyroglobulin (Tg) [9, 10] although all of these 
indicators have some limitations.
Urinary iodine is a sensitive indicator of recent iodine 
intake [11, 12], but not of thyroid function. Since most of 
the iodine that is absorbed is excreted in the urine, the 
urinary iodine level is a good marker of a recent dietary 
intake. Spot urine sample is recommended for popula-
tion based studies [13, 14]. Thyroid size measurement 
reflects a population’s history of iodine nutrition, but not 
present iodine status [15]. It may not return to normal 
size for months or years after correction of ID; thus, it is 
not a good indicator of IDD after introduction of iodized 
salt [9]. TSH level in neonates are particularly sensitive to 
ID, although the cost of implementing a TSH screening 
program is too high for most developing countries [16]. 
Tg, the most abundant thyroid specific protein, with no 
known physiologic role outside the thyroid [17], is a pri-
mary precursor in the production of thyroid hormones. 
Tg assay has recently been adapted for use on dried blood 
spots (DBS) and the normal reference range for SAC has 
been established [17]. The value of Tg as an indicator of 
global IDD status has yet to be fully explored [4], but as 
the results from population studies indicate, Tg seems to 
be a valuable indicator of thyroid status in respect to its 
sensitivity to recent changes in iodine status [9]. An ade-
quate iodine intake may be assumed when TSH and Tg 
values are at the lower end of the normal range [18]. In 
iodine-deficient populations, serum fT3 may be increased 
or remains unchanged, and serum fT4 usually declines 
[19, 20]. But, these changes often lie within the normal 
range, and appear similar with iodine-sufficient individu-
als, which makes thyroid hormone levels a nonspecific 
measure of iodine status [16].
Iodized salt has been considered as the most effective 
tool to control and prevent IDD. Universal salt iodization 
(USI) has been significantly successful in most countries 
[21]. The goal of USI (>90 % households using adequately 
iodized salt) has already been achieved by many coun-
tries while others have not yet reached these levels [9, 16]. 
Delivery of iodized salt is sporadic, especially in remote 
areas, and the salt is often left outside, thus causing a 
rapid loss of iodine in inclement weather [9]. Recent data 
indicate that ID is still a significant public health prob-
lem in Nepal, with 19.4 % SAC having UIE <100 µg/L [1, 
22]. Thus, this study aims to determine the current iodine 
and thyroid status in school children in the Tehrathum 
and Morang districts of Eastern Nepal by measuring UIE, 
serum Tg, fT3, fT4, TSH and salt iodine content (SIC). 
The study will also determine the relationships between 
these measures to help guide future studies to measure 
the incidence of IDD efficiently.
Methods
Study sites and participants
This cross sectional study was designed to study iodine 
nutrition and thyroid status of randomly selected schools 
in Tehrathum district, situated in the hilly region and 
Morang district lying in the plains region of Eastern 
Nepal. It used the iodine status indicators namely UIE, 
serum Tg and SIC, which are recommended by WHO, 
UNICEF and the International Council for Control of 
Iodine Deficiency Disorders (ICCIDD) [16]. We have clas-
sified the iodine status of median UIE according to epi-
demiological criteria developed by WHO, UNICEF and 
ICCIDD for SAC (≥6 years) as severe ID (<20 µg/L), mod-
erate ID (20–49  µg/L), mild ID (50–99  µg/L), adequate 
iodine nutrition (100–199  µg/L), above requirements 
(100–199 µg/L) and excessive (>300 µg/L) [16]. The study 
was conducted over 13 months (from May 2010 to June 
2011). A total of seven primary schools, three from Teh-
rathum and four from Morang were selected using ran-
dom number table from the list of all the schools in these 
districts separately, as a primary sampling unit. Then 
all the children aged 6–11  years in these schools were 
included as the ultimate sampling unit. This sampling 
design was equivalent to conducting a 30  ×  20 cluster 
sampling (600 children) as the average number of children 
aged 6–11 years in each school was found to be around 90 
(630 children). A total of 640 urine and salt samples from 
the children’s households were collected and screened for 
UIE and SIC. Out of 640 children, blood samples from 
155 children with parental consent were collected for the 
estimation of serum TSH, fT3, fT4 and Tg.
Ethical clearance
Prior visits were made to the respective schools; the 
objectives of the study and its benefits were explained 
to the school authorities and children’s guardians. The 
ethical clearance for this study was approved by the Insti-
tutional Ethical Review Board (IERB) of B.P. Koirala Insti-
tute of Health Sciences (BPKIHS), Dharan, Nepal and 
included permission to obtain urine and blood samples 
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from SAC 6–11  years. Written consent was obtained 
from guardians of the children and verbal assent was 
taken from children.
Sample collection and analysis
Spot urine samples (n =  640) were collected from all the 
eligible children in a clean sterile pre-labeled tightly screw 
capped 15 mL plastic vials. Clean, airtight plastic pouches 
were distributed to the same eligible children with clear 
instructions for collecting the salt samples from their 
homes, which were collected the following day. Every effort 
was made to ensure that urine samples were not contami-
nated. The children went to the toilet individually so that 
urine could not be ‘shared’. Blood samples (3 mL) were col-
lected by venipuncture in a plain red capped vacutainer 
(BD vacutainer, USA) and transported to the biochemistry 
laboratory at BPKIHS, maintaining a cold chain. The blood 
was centrifuged immediately at 3000  g for 10  min, and 
serum was separated into two aliquots and stored at −20 °C 
until analysis. Batch analyses were performed with calibra-
tors and standards. Urinary iodine levels were assessed by 
the Ammonium Persulfate Digestion Microplate (APDM) 
method using the Sandell-Kolthoff reaction in a specially 
designed apparatus, sealing cassette (Hitachi, Japan) [23] in 
microplate format. Urinary iodine controls L1 (72–96 µg/L) 
and L2 (260–348 µg/L) (Seronorm, Norway) were analyzed 
to obtain intra-assay CVs (L1 = 7.4 %, L2 = 3.3 %) and inter 
assay CVs (L1 = 23.5 %, L2 = 11.26 %) respectively. Meas-
urement of Tg was undertaken using a standard kit (Gen-
esis Diagnostics Ltd, UK) [24] whereas TSH, fT3 and fT4 
analyses were done using a HUMAELISA kit (Human® 
Diagnostics, Germany). Thyroid function status was deter-
mined according to the biochemical criteria taking consid-
eration of the reference range provided in the kit, which 
reported fT3 2.16–6.47  pmol/L, fT4 10.32–28.38  pmol/L, 
TSH 0.39–6.16 mIU/L and Tg 3–50 µg/L. Subclinical hypo-
thyroidism are considered when TSH >6.16  mIU/L with 
fT3 and fT4 in the reference range whereas in subclinical 
hyperthyroidism, TSH <0.39 mIU/L with fT3 and fT4 in the 
reference range.
Statistical analysis
Data were first entered in Microsoft Excel™ 2010 and 
then converted to Statistical Package for Social Sciences 
(SPSS) version 16.0 (SPSS Inc., Chicago, USA). Data 
were first checked for the normality using Kolmogo-
rov–Smirnov (KS) test. For normally distributed data, 
Pearson’s correlation test and the unpaired student ‘t’ test 
were applied. If data were not normally distributed, then 
either they were log transformed or non-parametric tests 
were applied. Multiple linear regression analysis was per-
formed to find the main predictor of UIE among SAC. A 
p value of less than 0.05 was considered statistically sig-
nificant at 95 % confidence interval (CI).
Results
Biochemical characteristics
Urinary iodine excretion (UIE)
The median UIE values of single spot urine tests are pre-
sented in Table 1 and results are reported as a population 
Table 1 Urinary iodine concentration in relation to sex, age and location
UIE urinary iodine excretion, IQR interquartile range, ID iodine deficiency
a Applied Mann–Whitney test
b Applied Kruskall–Wallis test, For Post Hoc (pairwise) comparison of age group, Mann–Whitney tests were applied
UIE (µg/L) UIE category (µg/L)














n Median IQR % n % n % n % n % n % n
Total 640 292 181; 411 1.7 11 2.2 14 4.5 29 19.7 126 23 147 48.9 313
Gendera
 Male 312 301 196; 412 0.3 1 2.2 7 2.9 9 20.2 63 24.4 76 50 156
 Female 328 285 163; 410 3 10 2.1 7 6.1 20 19.2 63 21.6 71 47.9 157
Age (years)b
 6–7 168 269 140; 390 4.2 7 3.6 6 6 10 25 42 19 32 42.3 71
 8–9 226 320 209; 429 1.3 3 2.2 5 4.4 10 15 34 24.3 55 52.7 119
 10–11 246 297 195; 411 0.4 1 1.2 3 3.7 9 20.3 50 24.4 60 50 123
Districta
 Tehrathum 274 346 205; 463 1.5 4 2.9 8 5.1 14 15 41 16.1 44 59.5 163
 Morang 366 270 167; 358 1.9 7 1.6 6 4.1 15 23.2 85 28.1 103 41 150
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not individuals as suggested by Zimmerman et  al. [14]. 
The overall median UIE is 291.8  µg/L (IQR 181.3–
411.5 µg/L). Table 1 shows that boys were found to have 
a higher median UIE than girls but it was not statistically 
significant (p  =  0.162). We found significant difference 
between age groups for UIE (p = 0.012). There were sig-
nificant differences between 6–7 and 8–9 age categories 
for UIE (p  =  0.004). Based on UIE, 1.7  % of SAC had 
severe, 2.2 % had moderate and 4.5 % had mild ID. High 
median values for UIE can be a cause for concern because 
this can have an adverse effect on health and is discussed 
more fully later. Figure 1 depicted the iodine status of the 
SAC of both Tehrathum and Morang districts based on 
the UIE.
Salt iodine content (SIC)
In Tehrathum, 34.7 % (n = 95) of the children consumed 
non-packaged salt in their household as compared 
to only 3.3  % (n =  12) in Morang, which is statistically 
significant (p  <  0.0001). Morang had 98.6  % (n  =  361) 
children with SIC >15  ppm as compared to Tehrathum 
86.9 % (n = 238) in concordance with studies carried out 
in demographically and geographically similar regions 
[25, 26]. The mean SIC for Tehrathum and Morang by 
salt iodometric method was 39.4 (SD 18.0) and 43.3 (SD 
12.0) ppm respectively. We found that SAC having UIE 
>100 µg/L was associated with packet salt consumption 
(p = 0.005). A larger percentage (94.5 %) of school chil-
dren who consumed packet salt have been found to have 
UIE values >100 µg/L.
Serum specimens
Mean, standard deviation and median with inter quartile 
range (IQR) of serum fT3, fT4, TSH and Tg in Tehrathum 
and Morang districts are summarized in Tables  2, 3. In 
this study, hypothyroidism or hyperthyroidism is classi-
fied by considering all three thyroid related hormones.
Serum thyroglobulin (Tg)
The recently developed Tg assay for use on dried whole 
blood spots with CRM-457 Tg standards had a reference 
range (the 3rd and 97th percentiles, 5–14 year old chil-
dren, euthyroid, anti TgAb negative, residing in long term 
iodine sufficiency) of 4–40  µg/L [27]. Accordingly, 9.5 
and 1.9  % of the school children in the Tehrathum and 
Morang districts have Tg-based iodine deficiency [27]. 
The majority of the children’s Tg values fall in the nor-
mal reference range (See Fig. 2). Our result showed that 
median Tg concentration for Tehrathum and Morang was 
19.5 µg/L (11.0–29.0 µg/L) and 10.9 µg/L (6.6–17.7 µg/L) 
respectively. We observed significant negative correlation 
between Tg and UIE in concordance with the study done 
by Zimmermann et al. [17, 28].
When Tg was compared with UIE, median Tg of 
12.4  µg/L (0.32–108.3  µg/L) and 22.5  µg/L (5.9–
205.4  µg/L) were observed in children whose UIE 
>100  µg/L (n  =  119) and children with UIE <100  µg/L 
(n = 36) respectively. The data were normally distributed 
for fT3 and fT4 but positively skewed for Tg and TSH, so 
natural log transformation was undertaken prior to anal-
ysis by one-way ANOVA. No significant association was 
found between fT3, fT4 and TSH. Significant association 
existed between Tg and UIE (p  =  0.016), but post hoc 












































Urinary Iodine Excretion 
Tehrathum Morang
Fig. 1 Percent distribution of urinary iodine concentrations in pri-
mary school children in the Tehrathum and Morang districts
Table 2 Mean (SD), median with IQR of serum Tg, fT3, fT4 and TSH
Reference range: Tg (3–50 µg/L), TSH (0.39–6.16 mIU/L), fT3 (2.16–6.47 pmol/L), fT4 (10.32–28.38 pmol/L)
Tg serum thyroglobulin, fT3 free triiodothyronin, fT4 free thyroxine, TSH thyroid stimulating hormone
Tehrathum (n = 78) Morang (n = 77) Total (n = 155)
Mean SD Median IQR Mean SD Median IQR Mean SD Median IQR
Tg (µg/L) 25.7 28.3 19.5 11.0; 29.0 14.5 12.5 10.9 6.6; 17.7 20.1 22.6 14.3 8.8; 25.3
fT3 (pmol/L) 4.0 1.1 3.7 3.4; 4.6 4.2 1.1 4.0 3.4; 4.9 4.2 1.1 4.0 3.4; 4.6
fT4 (pmol/L) 15.5 3.9 15.5 12.9; 18.1 18.1 3.9 16.8 15.5; 19.4 16.8 3.9 16.8 12.9; 19.4
TSH (mIU/L) 4.5 4.7 3.5 2.3; 4.9 4.4 2.8 4.1 2.5; 5.8 4.5 3.8 3.6 2.4; 5.5
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Thyroid function status
District wise distribution of sub-clinical hypothyroidism 
was found to be 16.7 % (n = 13) and 19.5 % (n = 15) in 
Tehrathum and Morang respectively (see Fig.  3). Sub-
clinical hyperthyroidism was found in only two cases in 
Morang district. A total of 18.1 % of 155 cases, including 
13.9 % (n = 11) boys and 22.4 % (n = 17) girls had sub-
clinical hypothyroidism. Only two boys had subclinical 
hyperthyroidism. Fisher’s exact test shows that there was 
no significant association of thyroid dysfunction with sex 
(p = 0.153).
Correlation of UIE, salt iodine content (SIC) and thyroid 
parameters
We applied Spearman’s rho correlation test for UIE, SIC, 
Tg and TSH whereas Pearson’s correlation test was used 
for fT3 and fT4 only. A significant positive correlation 
was found between UIE and SIC (r = 0.349, p < 0.0001), 
a negative correlation between UIE and Tg (r = −0.236, 
p = 0.003), and a negative correlation between UIE and 
TSH (r = −0.132, p = 0.102). A significant positive cor-
relation was found between serum fT3 and fT4 (r = 0.284, 
p < 0.0001). No statistically significant correlations were 
found among fT3, fT4 and Tg. Serum Tg correlated 
Table 3 Characteristics of  Tg, TSH, fT4 and  fT3 of  differ-
ent iodine status in primary school age children (n = 155) 
of Tehrathum and Morang districts
One way ANOVA test shows significant difference (p = 0.016) between Tg and 
UIE category. Post hoc analysis was carried out for Tg, fT3, fT4 and TSH by UIE 
categories separately. No statistically significant difference observed for other 
parameters (fT3, fT4 and TSH) with UIE category
Level of significance: * p < 0.05
ID iodine deficiency, Tg serum thyroglobulin, fT3 free triiodothyronine, fT4 free 
thyroxine, TSH thyroid stimulating hormone
a Non-normally distributed variables were log transformed
UIE category Tga (µg/L) fT3 (pmol/L) fT4 (pmol/L) TSHa (mIU/L)
Severe ID (n = 11)
 Mean 32.6 4.3 15.3 5.8
 SD 38.2 1.1 3.8 2.6
 Median 18.1 3.8 14.1 6.7
 IQR 12.8; 29.0 3.5; 5.7 12.9; 18.1 3.6; 7.5
Moderate ID (n = 14)
 Mean 39.5 4.4 16.2 4.1
 SD 59.3 1.1 3.5 2.9
 Median 21.0 4.0 17.0 3.3
 IQR 12.5; 35.9 3.7; 4.5 14.2; 19.4 2.1; 5.9
Mild ID (n = 29)
 Mean 25.5 4.3 16.8 4.7
 SD 16.0 1.1 4.3 2.2
 Median 22.7 4.3 16.3 4.1
 IQR 13.2; 31.1 3.2; 4.5 12.9; 19.4 3.5; 5.8
Adequate iodine nutrition (n = 126)
 Mean 15.3 4.1 17.2 3.8
 SD 9.8 1.2 4.6 2.0
 Median 13.7 4.0 16.6 3.5
 IQR 9.1; 18.7 3.4; 4.9 12.9; 20.6 2.2; 5.1
Above requirements (n = 147)
 Mean 18.6 3.8 16.4 5.3
 SD 14.4 1.1 4.2 6.4
 Median 15.2 3.6 15.6 3.7
 IQR 8.1; 25.1 3.1; 19.4 19.4; 12.9 2.3; 5.0
Excessive (n = 313)
 Mean 17.2 4.1 16.3 4.3
 SD 18.1 1.1 3.9 3.9
 Median 10.9 4.1 15.9 3.2





























Tg status of school children 
Tehrathum
Morang
Fig. 2 Serum Tg status in study subjects in Tehrathum and Morang 
districts. *According to the normal range (4–40 µg/L) provided by 
































Thyroid function status* 
Tehrathum
Morang
Fig. 3 Percent distribution of Thyroid function status in primary 
school children of the Tehrathum and Morang districts. *Not statisti-
cally significant association between thyroid function categories and 
school children of Tehrathum and Morang districts [p = 0.311 (χ2 
test)]
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positively with TSH (r = 0.285, p < 0.0001) and negatively 
with SIC (r = −0.222, p =  0.005). It is recognized that 
in spite of the highly significant correlations described 
above, the contribution to the total variance is small, 
leaving a high proportion of the variance unaccountable.
Multiple linear regression analysis
We applied multiple linear regression analysis taking UIE 
as the dependent variable and age, gender, location and 
salt type as independent variables. Model fit was found 
statistically significant (F =  11.37, p < 0.001) explaining 
6.7 % of the variation. The residual analysis showed error 
following normal distribution and having homogenous 
variance. This multivariate analysis showed that SAC of 
Morang district and using unpackaged salt having lower 
level of UIE (75.9 and 51.7 µg/L).
Discussion
The WHO has estimated the worldwide prevalence of ID 
is 36.4 % in SAC leading to debilitating iodine deficiency 
disorders (IDDs). Improvements in ID have mainly been 
achieved through universal salt iodization (USI) and after 
implementation, careful monitoring of progress towards 
sustainable elimination of IDD is essential [15, 17, 29]. 
The main advantage of supplementation with iodized 
salt is that it is used by all sections of a community irre-
spective of social and economic status. Iodized salt is 
consumed in the same level throughout the year and 
the production is often confined to a few centers which 
means that processing can occur on a larger scale and 
with better controlled conditions [30]. Globally, iodine 
deficiency control programs using iodized salt have sig-
nificantly reduced IDDs, but many countries still have 
weak or nonexistent national programs.
In Nepal, successive government administrations 
have shown concern about ID but have not been capa-
ble of implementing a successful USI program through-
out Nepal. This has in part been due to major changes in 
political control and financial instability. Also, Nepal is 
made up of particularly diverse and challenging ecologi-
cal regions (mountain, hill, and terai), comprised three 
administrative zones and 16 districts. Salt Trading Cor-
poration (STC) Limited is the only authorized organiza-
tion for the salt iodization and distribution of iodized salt 
in Nepal. The Government of India is aiding the iodiza-
tion process. In Nepal, the recommended level of iodine 
is 50 mg iodine/kg of salt at the production level, 30 ppm 
at retail shop level and 15 ppm at household level. IDD 
status of Nepal can be improved by increasing the acces-
sibility of the adequately iodized salt in all the areas 
including the remote places of hills and mountains [1]. In 
spite of this the government of Nepal has been engaged 
in surveys to study the incidence of ID since 1998. There 
are several indicators that may be used to determine the 
iodine status of individuals and a population and will be 
discussed in more detail below [16]. The WHO/UNICEF/
ICCIDD [12] suggested that to be considered an iodine 
sufficient region, more than 50 % of the school children 
should have UIE level of (100  µg/L) or more, and not 
more than 20 % of samples should have UIE level of less 
than (50  µg/L). According to the Nepal National Sur-
vey and Impact study for IDDs in 2007, children having 
UIE <100  µg/L were 26.1  % in mountain, 18.9  % in hill 
and 9.1  % in terai in eastern Nepal [1]. In our focused 
study, children with UIE <100 µg/L were 10.5 % in Teh-
rathum (hill) and 9.1 % in Morang (terai). Comparison of 
our studies to the previous Nepal National Survey data 
showed lower values of ID in the Tehrathum hill region 
we studied, but showed agreement with the data from the 
Morang terai region.
The reason for the discrepancy is not known but it 
could be due to the focused coverage (only 7 clusters) 
of the Tehrathum region as we were unable to reach the 
most remote parts of the districts due to security and 
logistics problem, a recognized limitation of the study. 
This discrepancy could also be explained by the timing 
of the nationwide surveys. These were completed with 
school children in 1995, 2005 and 2007, with median UIE 
values of 143.8, 188.0 and 202.88 µg/L respectively [1, 9]. 
Our study could simply be showing the continued trend 
of sustainable improvement of UIE status of school chil-
dren, which is supported by the previous studies [31–33]. 
These results provide an initial ‘snapshot’ of an iodine 
status in these populations.
Interestingly, the UIE in 90.3 % of our population was 
higher than the WHO cut off point (100  µg/L) and is 
cause for concern because excessive iodine intake can be 
detrimental to health. Our study also showed interesting 
findings with almost 50 % having excessive UIE, though 
salt sample from their respective homes showed iodine 
concentrations within desired limits, with only approxi-
mately 7 % showing more than 60 ppm (See Fig. 4). This 
is of concern because elevated iodine can lead to induced 
hyperthyroidism and autoimmune thyroid disease. It 
is a challenging scenario to consider that the serious 
consequences of ID can coexist with those of excessive 
iodine. One potential source of high iodine values may 
be due to the eating habits of this particular population 
with frequent consumption of high-iodine uncooked 
instant noodles and flavor sachets in their lunch break. 
The high values for those using packaged salt are surpris-
ing. They exceed the levels of 15–40 ppm recommended 
by the WHO. One explanation is that when packaged 
salt, which is produced at a level of 50  ppm, is trans-
ported and stored, it then retains a much higher iodine 
level than originally anticipated. We observed this in 
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our study, something that was similarly noted in a study 
undertaken in the Khumbu region of Nepal by Heydon 
et  al. [34]. This illustrates further how regular sampling 
of iodine status and basic education about nutritional 
supplements are necessary so that the appropriate action 
taken to increase or decrease iodine intake.
This leads directly into the consideration of the type 
of testing that should be conducted to assess the iodine 
status of individuals and populations accurately. Meas-
urement of serum Tg was recommended by the WHO 
in 1994 as a more sensitive indicator for thyroid cell 
mass and as a better monitor for iodine status than the 
other three indicators, UIE, Total goiter rate (TGR), and 
serum TSH [35]. The WHO also suggested that a median 
Tg concentration of <10  µg/L in a population indicated 
iodine sufficiency [35]. However, data confirming Tg cut-
off value were limited.
In a recent study by Zimmerman et al., the cut off point 
for median Tg of 13  µg/L was proposed using clusters 
with median UIE in the range of 100–299  µg/L, after 
CRM-457 standardization, which indicates iodine suf-
ficiency in a population of school-aged children [28]. 
There were technical problems in measurements of Tg 
including large interassay variability and lack of reference 
data for Tg in healthy, iodine-sufficient school age chil-
dren [28, 36].
The median Tg in this study was lower than the cut-off 
point estimated by the manufacturer (50 µg/L) and Zim-
mermann et  al. [27] as reported in the results section. 
We propose that the Tg values obtained in this study 
could be ranked as iodine sufficiency regions if the cut-
off of 50  µg/L is applied. The UIE and SIC estimation 
in this study suggests, with the limitation of single spot 
sample, an iodine sufficiency region comparable with 
the significant decrease of Tg level. Thus, the median Tg 
concentration could be used as a suitable indicator for 
monitoring iodine status.
Our focused study of UIE levels in two districts in 
Nepal gave a reasonable representation of the region 
and it is unlikely that there are large groups of the pop-
ulation where iodine deficiency has not been assessed. 
Our results agree with previous trends seen in national 
surveys showing that iodized salt programs are steadily 
improving the iodine deficiency problems that plagued 
Nepal and other developing countries in recent times.
Limitations
The present study has some limitations. Firstly to gen-
eralize the result to whole populations, a larger sample 
size of school children is required that would need con-
siderably more time and resource. Secondly, we have not 
assessed Anti Tg Antibody, which may interfere with the 
result of serum Tg and we have also not measured Anti 
thyroid Antibody, which can help to differentiate the eti-
ology of subclinical hypothyroidism. In both these cases, 
it was due to limited resources.
Conclusion
There has been considerable progress in the last decade 
towards the elimination of iodine deficiency in Nepal 
reflecting the validity of the WHO strategy of salt iodi-
zation programs. Our focused study on two districts of 
Nepal, one hill district (Tehrathum) and one terai district 
(Morang), showed continued improvement in the iodine 
status of the population based on UIE levels suggesting 
that there is increasing lower ID in these regions. Also, 
promising results from our study found that the propor-
tion of households consuming adequately iodized salt 
have reached target levels of >90  % in the Morang dis-
trict and are steadily approaching those levels in the Teh-
rathum district. These results reflects the efforts made by 
countries to implement effective IDD control programs 
and is evidence of the successful collaboration and part-
nership between IDD control agencies, mostly the health 
authorities and the salt industries.
The results of our study also uncovered an unexpected 
and complicating issue of surprisingly high levels of 
iodine excess in the same population with a proportion 
of people showing low iodine status. This complicates 
a standardized intervention strategy that only focuses 
on salt iodization supplementation and suggests that an 
intervention approach needs to be a more dynamic tai-
lored strategy. This new strategy would have to include 
rapid testing, timely intervention, and basic nutritional 
education specific to the population. This will require 
coordination between non-government and government 
institutions and every effort needs to be made to ensure 






























Salt iodine concentration by iodometric titration method (ppm) 
Tehrathum Morang
Fig. 4 Percent distribution of salt iodine concentrations in primary 
school children in the Tehrathum and Morang districts
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Even with the substantial progress that has been made, 
the challenge now is to improve the quality of the data 
in order to generate appropriate and timely interventions 
and to track progress more accurately and rapidly.
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